This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
IQ3Corp Enters Voluntary Administration MT
IQ3Corp Ltd Announces Executive Changes CI
IQ3Corp Investee OncoTEX Secures Gold Compound Platform Technology License; iQ3Corp Shares Surge 15% MT
Iq3corp Ltd Reports Earnings Results for the Full Year Ended June 30, 2021 CI
IQ3Corp Ltd Announces Executive Changes CI
IQ3Corp Ltd Announces Resignation of Monika Pawel as Non-Executive Director CI
IQ3Corp Limited Appoints Peter Mercouris as A Director CI
Iq3corp Ltd Reports Earnings Results for the Half Year Ended December 31, 2020 CI
IQ3Corp Limited Announces Executive Changes CI
Iq3corp Ltd Reports Earnings Results for the Full Year Ended June 30, 2020 CI
IQ3Corp Ltd Announces Board Changes CI
Iq3corp Ltd Reports Earnings Results for the Half Year Ended December 31, 2019 CI
Iq3corp Ltd Reports Earnings Results for the Full Year Ended June 30, 2019 CI
IQ3 Corp Announces Executive Changes CI
Iq3corp Ltd Reports Earnings Results for the Half Year Ended December 31, 2018 CI
IQ3Corp Limited Reports Consolidated Earnings Results for the Year Ended June 30, 2018 CI
Iq3corp Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2018 CI
IQ3Corp Limited Announces Address Changes CI
IQ3Corp Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2017 CI
IQ3Corp Limited Announces Board Changes CI
IQ3Corp Limited Announces Resignation of Spiro Sakiris from the Board CI
Iq3corp Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2017 CI
IQ3Corp Limited Reports Preliminary Unaudited Consolidated Earnings Results for the Year Ended June 30, 2017 CI
IQ3Corp Limited Reports Unaudited Consolidated Earnings Results for the Half Year Ended December 31, 2016 CI
IQ3Corp Limited Announces Board Changes CI
Chart IQ3CORP
More charts
iQ3Corp Ltd is an Australia-based company that is engaged in the provision of capital raising and corporate advisory services to listed and unlisted companies in the life science industry. The Company's segments include consulting services and shared services. consulting services segment includes capital raising and corporate advisory fees. shared services segment includes office and shared services revenue. It provides advices to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance to corporations, partnerships, institutions, governments, and individuals. It offers various services, such as initial public offerings, listings, private equity, merger and acquisitions, sell-side advisory, buy-side advisory, structured finance and N.S.X. nominated advisor. The Company has six wholly owned subsidiaries.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. IQ3 Stock
  4. News IQ3CORP
  5. IQ3Corp Investee OncoTEX Secures Gold Compound Platform Technology License; iQ3Corp Shares Surge 15%